iLet Real-World Data Speaks for Itself.

Proven outcomes across all populations. Because you deserve to see the whole picture.

OUR PROMISE

Data transparency is our
 promise to you.

Making a therapy decision for your patients is one of the most important things you do. That decision should be informed by data that reflects the real world and not a curated subset of it.

That’s why we built this page. We want to show you every patient, every baseline, every outcome. No filters. No fine print.

So you can make the decision that is best for your patient.  With proven outcomes like these, there’s nothing to hide.

OUR PRINCIPLES

Transparency Is in Our DNA

6 principles that guide how we report iLet real world outcomes:

  • Real-world populations
    Our data reflects the actual patients on the iLet — not a hand-picked group.
  • Designed to include
    Our inclusion criteria are simple: a baseline HbA1c and at least 2 weeks of data uploaded to the cloud.
  • The hardest patients count
    When we look at subgroups, we focus on harder-to-treat populations.
  • The whole story
    We show baseline and follow-up data. The starting point matters.
  • Continuous since launch
    Our data is refreshed near real-time, not a snapshot from a narrow window.
  • High representation
    Our sample size represents a high percentage of all patients on the iLet.

Real-World Data

Our only inclusion criteria: Baseline HbA1c and at least 2 weeks of data on the iLet uploaded to the cloud.

Use the dropdowns below to see actual patient outcomes.

Evaluating Data

How to compare the iLet data to other studies of automated insulin delivery systems:

1

Check the sample size

How many patients are included? What percentage of total users does that represent?

2

Look for a baseline

Does the study show where patients started? An outcome without a starting point is half the story.

3

Understand the criteria

What were the inclusion and exclusion criteria? Were certain patients filtered out?

4

Ask about settings

Are results based on specific device settings? What percentage of users have those settings?

5

Consider the timeframe

Is this continuous data, or a snapshot from a specific period?

MM000205_B

Ready to GO BIONIC?

The iLet Bionic Pancreas automatically adjusts to your insulin needs so you don’t have to.

GO BIONIC

logo-white

Beta Bionics is a people-focused company dedicated to making diabetes easier for everyone, every day.

Safety Information – The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/user-resources, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/safety. DO NOT start to use the iLet Bionic Pancreas System without adequate training. Incorrect use may result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

Medical Disclaimer – This website is for information only and is not a substitute for medical advice and/or services from a healthcare provider. All personal health care decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs.

Copyright © 2026 Beta Bionics | Privacy Policy | Safety | Terms of Use | Cookies | Patents  | Code of Conduct